Belgium· BE-AMP-SAM663351-00

Anzupgo 20 mg/g

A delgocitinib product containing delgocitinib, registered in Belgium by Leo Pharma. The same ATC class is registered in 15 of our 19 countries.

ATC D11AH11

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about delgocitinibAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Delgocitinib is registered in 15 of 19 countries.

Countries holding a registration under ATC D11AH11 (delgocitinib), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
10 of them publish a price we can compare per daily dose

Search delgocitinib products by name

Delgocitinib · ATC D11AH11

15 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Franceprice
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Delgocitinib
Manufacturer: Leo Pharma
Country: Belgium (BE)
ATC code: D11AH11
ATC class: Delgocitinib
Defined daily dose: 40 mg, T
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Delgocitinib in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All delgocitinib products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

United Kingdom (Northern Ireland) · Anzupgo
Iceland · Anzupgo
Liechtenstein · Anzupgo
Norway · Anzupgo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/fcec5df0-ff5e-4bca-b6e8-bc4c6bc9f26a
GET /v1/drugs/fcec5df0-ff5e-4bca-b6e8-bc4c6bc9f26a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Cream",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Anzupgo 20 mg/g",
  "name_fr": "Anzupgo 20 mg/g",
  "name_nl": "Anzupgo 20 mg/g",
  "amp_code": "SAM663351-00",
  "strengths": [
    "20.0000",
    "20.0000",
    "20.0000",
    "10.0000",
    "10.0000",
    "0.2000",
    "0.2000",
    "72.0000",
    "72.0000"
  ],
  "pack_count": 3,
  "substances": [
    "Delgocitinib",
    "Benzyl Alcohol",
    "Butylhydroxyanisole",
    "Cetostearyl Alcohol",
    "Disodium Edetate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Delgocitinib",
  "authorisation_numbers": [
    "EU/1/24/1851/002",
    "EU/1/24/1851/001",
    "EU/1/24/1851/003"
  ]
}

API reference MCP server Plans

See everything about delgocitinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console